查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2159093

全自動核酸萃取系統市場：全球市場預測，2026-2032年

Fully Automated Nucleic Acid Extraction System Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，全自動核酸萃取系統市場將成長至 26.7 億美元，複合年成長率為 10.18%。

主要市場統計數據
基準年 2025 13.5億美元
預計年份：2026年 15億美元
預測年份 2032 26.7億美元
複合年成長率 (%) 10.18%

全自動核酸萃取系統：概述

全自動核酸萃取系統整合了樣品製備、純化和核酸回收功能，同時最大限度地減少了人工干預。隨著檢查室對可重複性工作流程、污染風險管理和高效利用專業人員的需求日益成長，這類系統在分子診斷、基因組學、檢驗醫學和公共衛生檢測領域的重要性也日益凸顯。是否採用此類系統取決於多種因素，例如處理能力、檢體範圍、提取化學方法、工作流程柔軟性、儀器連接性和驗證要求。

自動化正在改變檢查室的工作流程和品管。

目前的趨勢是從獨立的萃取流程轉向標準化、整合的工作流程，將檢體接收、萃取、擴增、檢測和報告等環節連接起來。檢查室越來越重視密封或半密封處理、可追溯性、靈活的批次處理以及對多種檢體類型的支援。監管、勞動力短缺、檢測分散化以及對穩定週轉時間的需求，都推動了對能夠減少人為因素差異並維持分析控制的系統的需求。

人工智慧將提升流程管理水平，但驗證仍然至關重要。

人工智慧 (AI) 可以透過異常檢測、預測性維護、基於影像的耗材和檢體評估、自適應工作流程調度以及識別異常執行情況來改善自動化提取流程。此外，整合的數據環境可以輔助試劑追蹤、品管審查和操作最佳化。然而，人工智慧並不能取代實驗檢驗的方案、網路安全措施、可解釋的決策邏輯、人工監督以及對適用醫療設備和檢查室法規的遵守。其最實際的短期價值不在於取代已驗證的萃取方法，而是加強檢查室控制。

區域洞察：基礎設施和測試重點驅動部署

北美地區擁有成熟的分子偵測基礎設施、完善的檢查室認證體系，以及整合化、可追溯自動化系統的需求。歐洲兼具先進的診斷能力和對品質、隱私及合規性的嚴格要求，同時，歐洲市場也反映出各國採購和報銷結構的差異。亞太地區擁有高度發展的檢查室系統和快速發展的診斷能力，因此既需要高通量平台，也需要能夠適應不同規模實驗室的系統。拉丁美洲的特點是基礎設施不平衡、依賴進口，以及需要能夠在中心實驗室和區域檢查室運作的可靠設備。中東地區則著重先進的醫療能力、國家級檢測能力和技術驅動型服務。同時，非洲的情況較為複雜，既有參考檢查室，也有新興的分子檢測網路，同時也面臨人力資源短缺以及對耐用且易於維護的設備的需求。

集團洞察：經濟和安全夥伴關係影響檢查室優先事項

在東協市場，擴充性的診斷技術、區域疾病監測以及能夠相容於不同檢查室基礎設施的系統通常是優先考慮的因素。金磚國家成員國對國內製造業、公共衛生計畫和研究能力的投入各不相同，因此各參與經濟體的採購需求差異顯著。歐盟強調統一的品質標準、資料管治和跨境醫療基礎設施。同時，七國集團（G7）國家通常將先進的研究能力與嚴格的檢驗和網路安全要求結合。海灣合作理事會（GCC）國家正在投資建設現代化的醫療和檢測基礎設施，除了數位化連接的設施外，通常還強調集中化的專業知識。北約成員國則特別重視具有韌性的醫療供應鏈、緊急準備、互通性以及緊急情況下檢測業務的連續性。

國家概況：各國的具體能力、法規和檢查室結構至關重要。

澳洲和加拿大需要適合地理分散式服務和健全的品質監管的系統。巴西和墨西哥由於檢查室能力和物流方面的差異，優先考慮工作流程的穩健性和服務支援。中國和印度將大規模研發活動與多元化的採購環境和國內能力建設結合。法國、德國、義大利、西班牙和英國在複雜但各具特色的監管、採購和醫療保健系統下運作，因此互通性和檢驗的工作流程至關重要。日本和韓國強調準確性、可靠性、先進的檢查室自動化以及與現有醫療保健生態系統的整合。俄羅斯的需求受國內供應狀況、檢查室韌性和進口技術的運作環境的影響。在美國，分散的檢測格局、活躍的研究、監管合規性和與醫療保健系統的整合顯著影響系統的選擇。

自動化提取領域的領導者應優先考慮的問題

行業領導者在選擇設備前，應根據檢體類型、處理能力、人員配置模式和監管目標對工作流程進行分類。應優先考慮透明的效能檢驗、污染控制、開放或有明確文件記錄的互通性、安全連接和可靠的耗材供應。部署計劃應包括操作人員培訓、預防性保養、批次間檢驗、備份程序以及可衡量的品質指標，例如無效測試的頻率和實際工作時間。領導者還應全面評估操作複雜性，而不僅僅關注部署成本，並將人工智慧功能視為一種受控的決策支援功能，需要進行管治、審計和人工審核。

調查方法：基於證據評估驅動系統實施的因素。

本執行摘要對臨床診斷、分子檢測、基因組學、研究和公共衛生等領域的檢查室中全自動核酸萃取系統進行了結構化的定性評估。分析從多個角度組織研究結果，包括工作流程自動化、檢查室品質、基礎設施、法規、互聯互通、人才需求、區域背景、經濟和安全等級以及國家營運環境。國家和群體之間的比較是基於已記錄的醫療保健能力、檢查室組織結構、採購、監管預期和準備優先事項方面的差異，而非數值比較。本摘要未使用市場估算和預測。

結論：可靠的自動化需要符合性、檢驗和彈性。

全自動核酸萃取系統正從單純的便利型獨立工具發展成為重要的檢查室基礎設施。只有當自動化與檢體要求、效能檢驗、資料管治、服務能力以及本地操作條件相符時，其價值才能最大化。考慮到區域和國家差異，平衡標準化和柔軟性對於成功實施至關重要。那些能夠將穩健的工作流程設計、完善的監管、可互通的技術以及強大的供應和維護系統相結合的機構，最有可能實現可靠的檢查室性能。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：全自動核酸萃取系統市場：依產品類型分類

  • 桌上型系統
  • 高通量系統

第8章：全自動核酸萃取系統市場：依技術分類

  • 磁珠
  • 二氧化矽膜
  • 旋轉柱

第9章：全自動核酸萃取系統市場：依應用領域分類

  • 農業領域的檢查
  • 臨床診斷
    • 基因檢測
    • 感染疾病
      • 細菌
      • 寄生蟲
      • 病毒性的
    • 腫瘤學
  • 環境測試
  • 法醫分析
  • 藥物測試
  • 研究與開發
    • 表觀遺傳學
      • 染色質免疫沉澱分析法
      • 甲基化分析
    • 基因組學
      • 微陣列
      • 次世代定序
      • 桑格定序
    • 蛋白質體學
    • 轉錄組學
      • qPCR
      • RNA-Seq

第10章：全自動核酸萃取系統市場：以最終用戶分類

  • 學術研究機構
  • 生技公司
  • 診斷檢查室
  • 法醫科學研究所
  • 醫院和診所
  • 製藥公司

第11章：全自動核酸萃取系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：全自動核酸萃取系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：全自動核酸萃取系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Aurora Biomed, Inc.
  • AutoGen, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bioneer Corporation
  • BioTeke Corporation Wuxi Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin Molecular LLC
  • F. Hoffmann-La Roche AG
  • Hamilton Company
  • Hangzhou Bloer Technology Co., Ltd.
  • Illumina, Inc.
  • Jiangsu Bioperfectus Technologies Co., Ltd.
  • Merck KGaA
  • Promega Corporation
  • QIAGEN NV
  • Revvity, Inc.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Xi'an TianLong Science and Technology Co., Ltd.
  • Zymo Research Corporation

第16章 主要專家

Product Code: MRR-4654A89DBC64

The Fully Automated Nucleic Acid Extraction System Market is projected to grow by USD 2.67 billion at a CAGR of 10.18% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.35 billion
Estimated Year [2026] USD 1.50 billion
Forecast Year [2032] USD 2.67 billion
CAGR (%) 10.18%

Fully Automated Nucleic Acid Extraction Systems: Executive Overview

Fully automated nucleic acid extraction systems integrate sample preparation, purification, and nucleic acid recovery with limited manual intervention. Their relevance is increasing across molecular diagnostics, genomics, research laboratories, and public-health testing because laboratories require reproducible workflows, controlled contamination risk, and efficient use of skilled personnel. Adoption decisions depend on throughput, specimen compatibility, extraction chemistry, workflow flexibility, instrument connectivity, and validation requirements.

Automation Is Reshaping Laboratory Workflows and Quality Management

The landscape is shifting from isolated extraction steps toward standardized, connected workflows that link sample accessioning, extraction, amplification, detection, and reporting. Laboratories are placing greater emphasis on closed or semi-closed processing, traceability, flexible batch handling, and compatibility with diverse sample types. Regulatory scrutiny, workforce constraints, decentralized testing, and the need for consistent turnaround times are reinforcing demand for systems that reduce hands-on variability while preserving analytical control.

Artificial Intelligence Strengthens Process Control, but Validation Remains Essential

Artificial intelligence can improve automated extraction through anomaly detection, predictive maintenance, image-based assessment of consumables or samples, adaptive workflow scheduling, and identification of unusual run conditions. Connected data environments may also support reagent tracking, quality-control review, and operational optimization. However, AI does not remove the need for experimentally verified protocols, cybersecurity safeguards, explainable decision logic, human oversight, and compliance with applicable medical-device and laboratory regulations. The most practical near-term value lies in augmenting laboratory management rather than replacing validated extraction methods.

Regional Insights: Infrastructure and Testing Priorities Shape Adoption

North America is characterized by mature molecular-testing infrastructure, strong laboratory accreditation practices, and demand for integrated, traceable automation. Europe combines advanced diagnostics capacity with rigorous quality, privacy, and conformity expectations, while the European market also reflects differing national procurement and reimbursement structures. Asia-Pacific spans highly developed laboratory systems and rapidly expanding diagnostic capacity, creating demand for both high-throughput platforms and adaptable systems suited to varied facility sizes. Latin America is shaped by uneven infrastructure, import dependence, and the need for robust instruments that can operate across centralized and regional laboratories. The Middle East is emphasizing advanced healthcare capacity, national laboratory capability, and technology-enabled services, while Africa presents a mix of reference laboratories, emerging molecular-testing networks, workforce limitations, and requirements for durable, serviceable equipment.

Group Insights: Economic and Security Alliances Influence Laboratory Priorities

ASEAN markets commonly prioritize scalable diagnostics, regional disease surveillance, and systems compatible with varied laboratory infrastructure. BRICS members reflect diverse domestic manufacturing ambitions, public-health programs, and research capabilities, with procurement conditions differing substantially across participating economies. The European Union emphasizes harmonized quality expectations, data governance, and cross-border health infrastructure, while the G7 generally combines advanced research capacity with stringent validation and cybersecurity requirements. GCC countries are investing in modern healthcare and laboratory infrastructure, often favoring centralized expertise alongside digitally connected facilities. NATO members place additional emphasis on resilient medical supply chains, preparedness, interoperability, and continuity of laboratory operations during emergencies.

Country Insights: National Capacity, Regulation, and Laboratory Structure Matter

Australia and Canada require systems suited to geographically dispersed services and strong quality oversight. Brazil and Mexico face varied laboratory capacity and logistics conditions, making workflow robustness and service support important. China and India combine substantial research and diagnostic activity with diverse procurement environments and domestic capability development. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated but distinct regulatory, procurement, and healthcare structures, increasing the importance of interoperability and validated workflows. Japan and South Korea emphasize precision, reliability, advanced laboratory automation, and integration with established healthcare technology ecosystems. Russia's requirements are influenced by domestic supply considerations, laboratory resilience, and the operating environment for imported technologies. In the United States, decentralized testing, research intensity, regulatory compliance, and health-system integration strongly shape system selection.

Actionable Priorities for Leaders in Automated Extraction

Industry leaders should segment workflows by specimen type, throughput, staffing model, and regulatory purpose before selecting an instrument. They should prioritize transparent performance validation, contamination control, open or clearly documented interoperability, secure connectivity, and dependable consumable supply. Deployment plans should include operator training, preventive maintenance, lot-to-lot verification, backup procedures, and measurable quality indicators such as invalid-run frequency and hands-on time. Leaders should also assess total operating complexity rather than focusing only on acquisition cost, and should treat AI features as controlled decision-support capabilities requiring governance, auditability, and human review.

Research Methodology: Evidence-Based Assessment of System Adoption Drivers

This executive summary uses a structured qualitative assessment of fully automated nucleic acid extraction systems across clinical diagnostics, molecular testing, genomics, research, and public-health laboratories. The analysis organizes findings around workflow automation, laboratory quality, infrastructure, regulation, connectivity, workforce needs, regional conditions, economic and security groupings, and national operating environments. Country and group comparisons are interpretive rather than numerical and are based on documented differences in healthcare capacity, laboratory organization, procurement context, regulatory expectations, and preparedness priorities. No market estimates, market shares, or forecasts are used.

Conclusion: Reliable Automation Depends on Fit, Validation, and Resilience

Fully automated nucleic acid extraction systems are becoming strategic laboratory infrastructure rather than standalone convenience tools. Their value is greatest when automation is matched to specimen requirements, validated performance, data governance, service capability, and local operating conditions. Regional and national differences mean that a successful deployment model must balance standardization with flexibility. Organizations that combine robust workflow design, qualified oversight, interoperable technology, and resilient supply and maintenance arrangements will be best positioned to realize dependable laboratory performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Fully Automated Nucleic Acid Extraction System Market, by Product Type

  • 7.1. Introduction
  • 7.2. Bench Top Systems
  • 7.3. High Throughput Systems

8. Fully Automated Nucleic Acid Extraction System Market, by Technology

  • 8.1. Introduction
  • 8.2. Magnetic Bead
  • 8.3. Silica Membrane
  • 8.4. Spin Column

9. Fully Automated Nucleic Acid Extraction System Market, by Application

  • 9.1. Introduction
  • 9.2. Agricultural Testing
  • 9.3. Clinical Diagnostics
    • 9.3.1. Genetic Testing
    • 9.3.2. Infectious Disease
      • 9.3.2.1. Bacterial
      • 9.3.2.2. Parasitic
      • 9.3.2.3. Viral
    • 9.3.3. Oncology
  • 9.4. Environmental Testing
  • 9.5. Forensic Analysis
  • 9.6. Pharmaceutical Testing
  • 9.7. Research And Development
    • 9.7.1. Epigenetics
      • 9.7.1.1. Chromatin Immunoprecipitation
      • 9.7.1.2. Methylation Analysis
    • 9.7.2. Genomics
      • 9.7.2.1. Microarray
      • 9.7.2.2. Next Generation Sequencing
      • 9.7.2.3. Sanger Sequencing
    • 9.7.3. Proteomics
    • 9.7.4. Transcriptomics
      • 9.7.4.1. qPcr
      • 9.7.4.2. Rna Seq

10. Fully Automated Nucleic Acid Extraction System Market, by End User

  • 10.1. Introduction
  • 10.2. Academic Research Institutes
  • 10.3. Biotechnology Companies
  • 10.4. Diagnostic Laboratories
  • 10.5. Forensic Laboratories
  • 10.6. Hospitals And Clinics
  • 10.7. Pharmaceutical Companies

11. Fully Automated Nucleic Acid Extraction System Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Fully Automated Nucleic Acid Extraction System Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Fully Automated Nucleic Acid Extraction System Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Agilent Technologies, Inc.
  • 15.2. Analytik Jena GmbH
  • 15.3. Aurora Biomed, Inc.
  • 15.4. AutoGen, Inc.
  • 15.5. Beckman Coulter, Inc.
  • 15.6. Becton, Dickinson and Company
  • 15.7. bioMerieux S.A.
  • 15.8. Bioneer Corporation
  • 15.9. BioTeke Corporation Wuxi Co., Ltd.
  • 15.10. Bio-Rad Laboratories, Inc.
  • 15.11. DiaSorin Molecular LLC
  • 15.12. F. Hoffmann-La Roche AG
  • 15.13. Hamilton Company
  • 15.14. Hangzhou Bloer Technology Co., Ltd.
  • 15.15. Illumina, Inc.
  • 15.16. Jiangsu Bioperfectus Technologies Co., Ltd.
  • 15.17. Merck KGaA
  • 15.18. Promega Corporation
  • 15.19. QIAGEN N.V.
  • 15.20. Revvity, Inc.
  • 15.21. Takara Bio Inc.
  • 15.22. Tecan Trading AG
  • 15.23. Thermo Fisher Scientific Inc.
  • 15.24. Xi'an TianLong Science and Technology Co., Ltd.
  • 15.25. Zymo Research Corporation

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Fully Automated Nucleic Acid Extraction System Market, Years Considered for the Study
  • FIGURE 2. Global Fully Automated Nucleic Acid Extraction System Market, Research Design
  • FIGURE 3. Global Fully Automated Nucleic Acid Extraction System Market, Research Framework
  • FIGURE 4. Global Fully Automated Nucleic Acid Extraction System Market, Data Triangulation
  • FIGURE 5. Global Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Fully Automated Nucleic Acid Extraction System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Fully Automated Nucleic Acid Extraction System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Fully Automated Nucleic Acid Extraction System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Fully Automated Nucleic Acid Extraction System Market Segmentation & Coverage
  • TABLE 2. Global Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Bench Top Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Bench Top Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Bench Top Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global High Throughput Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global High Throughput Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global High Throughput Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 11. Global Magnetic Bead Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Magnetic Bead Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Magnetic Bead Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Silica Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Silica Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Silica Membrane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Spin Column Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Spin Column Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Spin Column Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 21. Global Agricultural Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Agricultural Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Agricultural Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Viral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Viral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Viral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Environmental Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Environmental Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Environmental Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Forensic Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Forensic Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Forensic Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Pharmaceutical Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Pharmaceutical Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Pharmaceutical Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Research And Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Research And Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Research And Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Epigenetics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Epigenetics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Epigenetics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Chromatin Immunoprecipitation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Chromatin Immunoprecipitation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Chromatin Immunoprecipitation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Methylation Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Methylation Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Methylation Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Genomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Genomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Genomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Proteomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Proteomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Proteomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Transcriptomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Transcriptomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Transcriptomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global qPcr Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global qPcr Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global qPcr Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global Rna Seq Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global Rna Seq Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global Rna Seq Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 91. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Forensic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Global Forensic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. Global Forensic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 103. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 106. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 108. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 109. Global Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 117. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 118. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 119. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 120. Asia-Pacific Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 121. North America Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 122. North America Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 123. North America Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 124. North America Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 125. North America Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 126. North America Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 127. North America Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 128. North America Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 129. North America Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 130. North America Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 131. North America Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 134. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 135. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 136. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 137. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 138. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 139. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 140. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 141. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 142. Latin America Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 143. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 144. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 145. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 146. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 147. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 148. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 149. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 150. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 151. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 152. Europe Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 153. Europe Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 155. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 156. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 157. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 158. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 159. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 160. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 161. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 162. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 163. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 164. Middle East Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 166. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 167. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 168. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 169. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 170. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 171. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 172. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 173. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 174. Africa Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 175. Africa Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 176. Global Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 177. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 178. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 179. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 180. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 181. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 182. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 183. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 184. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 185. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 186. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 187. ASEAN Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 188. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 189. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 190. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 191. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 192. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 193. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 194. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 195. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 196. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 197. GCC Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 198. GCC Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 199. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 200. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 201. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 202. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 203. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 204. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 205. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 206. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 207. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 208. European Union Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 209. European Union Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 210. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 211. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 212. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 213. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 214. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 215. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 216. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 217. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 218. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 219. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 220. BRICS Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 222. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 223. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 224. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 225. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 226. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 227. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 228. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 229. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 230. G7 Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 231. G7 Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 232. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 233. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 234. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 235. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 236. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 237. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 238. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 239. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 240. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 241. NATO Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 242. NATO Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 243. Global Fully Automated Nucleic Acid Extraction System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 244. United States Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 245. United States Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 246. United States Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 247. United States Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 248. United States Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 249. United States Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 250. United States Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 251. United States Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 252. United States Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 253. United States Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 254. United States Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 255. Canada Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 256. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 257. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 258. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 259. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 260. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 261. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 262. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 263. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 264. Canada Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 265. Canada Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 266. Mexico Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 267. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 268. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 269. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 270. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 271. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 272. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 273. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 274. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 275. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 276. Mexico Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 277. Brazil Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 278. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 279. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 280. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 281. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 282. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 283. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 284. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 285. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 286. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 287. Brazil Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 288. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 289. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 290. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 291. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 292. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
  • TABLE 293. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 294. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Research And Development, 2017-2032 (USD Million)
  • TABLE 295. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Epigenetics, 2017-2032 (USD Million)
  • TABLE 296. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Genomics, 2017-2032 (USD Million)
  • TABLE 297. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by Transcriptomics, 2017-2032 (USD Million)
  • TABLE 298. United Kingdom Fully Automated Nucleic Acid Extraction System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 299. Germany Fully Automated Nucleic Acid Extraction System Market Size, 2017-2032 (USD Million)
  • TABLE 300. Germany Fully Automated Nucleic Acid Extraction System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 301. Germany Fully Automated Nucleic Acid Extraction System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 302. Germany Fully Automated Nucleic Acid Extraction System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 303. Germany Fully Automated Nucleic Acid Extraction System Market Size, by Clinical Diag